Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 7.37481946 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.37481946 |
3 | L-phenylalanine metabolic process (GO:0006558) | 7.04447208 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.04447208 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.68014799 |
6 | indole-containing compound catabolic process (GO:0042436) | 6.05998802 |
7 | indolalkylamine catabolic process (GO:0046218) | 6.05998802 |
8 | tryptophan catabolic process (GO:0006569) | 6.05998802 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.94968788 |
10 | kynurenine metabolic process (GO:0070189) | 5.84521295 |
11 | bile acid biosynthetic process (GO:0006699) | 5.82485518 |
12 | glyoxylate metabolic process (GO:0046487) | 5.80242663 |
13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.77443664 |
14 | tryptophan metabolic process (GO:0006568) | 5.69218711 |
15 | neutrophil activation involved in immune response (GO:0002283) | 5.62619065 |
16 | cysteine metabolic process (GO:0006534) | 5.49314564 |
17 | sulfur amino acid catabolic process (GO:0000098) | 5.41678651 |
18 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 5.36608409 |
19 | urea cycle (GO:0000050) | 5.35874598 |
20 | urea metabolic process (GO:0019627) | 5.35874598 |
21 | cellular extravasation (GO:0045123) | 5.23295836 |
22 | complement activation, alternative pathway (GO:0006957) | 5.18816137 |
23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.16079446 |
24 | serine family amino acid catabolic process (GO:0009071) | 5.09093482 |
25 | bile acid metabolic process (GO:0008206) | 5.07282713 |
26 | negative regulation of fibrinolysis (GO:0051918) | 5.06068906 |
27 | high-density lipoprotein particle remodeling (GO:0034375) | 5.04103562 |
28 | protein carboxylation (GO:0018214) | 4.99865252 |
29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.99865252 |
30 | positive regulation of mast cell activation (GO:0033005) | 4.97500732 |
31 | nitrogen cycle metabolic process (GO:0071941) | 4.94726935 |
32 | glycosphingolipid catabolic process (GO:0046479) | 4.94173376 |
33 | regulation of protein activation cascade (GO:2000257) | 4.93820550 |
34 | regulation of fibrinolysis (GO:0051917) | 4.86899210 |
35 | lysine metabolic process (GO:0006553) | 4.85367029 |
36 | lysine catabolic process (GO:0006554) | 4.85367029 |
37 | aromatic amino acid family metabolic process (GO:0009072) | 4.84352097 |
38 | homocysteine metabolic process (GO:0050667) | 4.78953509 |
39 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.77055165 |
40 | positive regulation of mast cell degranulation (GO:0043306) | 4.77055165 |
41 | regulation of triglyceride catabolic process (GO:0010896) | 4.67335855 |
42 | regulation of complement activation (GO:0030449) | 4.67001401 |
43 | eosinophil chemotaxis (GO:0048245) | 4.66861024 |
44 | amino-acid betaine metabolic process (GO:0006577) | 4.63358508 |
45 | tyrosine metabolic process (GO:0006570) | 4.62852141 |
46 | alpha-amino acid catabolic process (GO:1901606) | 4.61142478 |
47 | acylglycerol homeostasis (GO:0055090) | 4.54048736 |
48 | triglyceride homeostasis (GO:0070328) | 4.54048736 |
49 | eosinophil migration (GO:0072677) | 4.48791833 |
50 | oligosaccharide catabolic process (GO:0009313) | 4.46397976 |
51 | plasma lipoprotein particle remodeling (GO:0034369) | 4.44065520 |
52 | protein-lipid complex remodeling (GO:0034368) | 4.44065520 |
53 | macromolecular complex remodeling (GO:0034367) | 4.44065520 |
54 | cellular ketone body metabolic process (GO:0046950) | 4.43318397 |
55 | response to peptidoglycan (GO:0032494) | 4.43048822 |
56 | regulation of cholesterol esterification (GO:0010872) | 4.42862914 |
57 | glycolipid catabolic process (GO:0019377) | 4.42615313 |
58 | reverse cholesterol transport (GO:0043691) | 4.38778085 |
59 | plasma lipoprotein particle clearance (GO:0034381) | 4.37953676 |
60 | bile acid and bile salt transport (GO:0015721) | 4.34031236 |
61 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.32931570 |
62 | ethanol oxidation (GO:0006069) | 4.30980970 |
63 | coenzyme catabolic process (GO:0009109) | 4.30646349 |
64 | cellular amino acid catabolic process (GO:0009063) | 4.30090196 |
65 | negative regulation of sterol transport (GO:0032372) | 4.28602715 |
66 | negative regulation of cholesterol transport (GO:0032375) | 4.28602715 |
67 | glycine metabolic process (GO:0006544) | 4.28442433 |
68 | indolalkylamine metabolic process (GO:0006586) | 4.27915147 |
69 | angiotensin maturation (GO:0002003) | 4.21595972 |
70 | serine family amino acid metabolic process (GO:0009069) | 4.20992454 |
71 | phospholipid efflux (GO:0033700) | 4.19396144 |
72 | cellular glucuronidation (GO:0052695) | 4.19109050 |
73 | regulation of mast cell degranulation (GO:0043304) | 4.18297520 |
74 | amine catabolic process (GO:0009310) | 4.17529632 |
75 | cellular biogenic amine catabolic process (GO:0042402) | 4.17529632 |
76 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 4.15588199 |
77 | glutamate metabolic process (GO:0006536) | 4.08600376 |
78 | benzene-containing compound metabolic process (GO:0042537) | 4.04826335 |
79 | imidazole-containing compound metabolic process (GO:0052803) | 4.04560929 |
80 | cellular modified amino acid catabolic process (GO:0042219) | 4.04455906 |
81 | acetyl-CoA metabolic process (GO:0006084) | 4.03676638 |
82 | short-chain fatty acid metabolic process (GO:0046459) | 4.02995032 |
83 | regulation of mast cell activation (GO:0033003) | 3.97527743 |
84 | ceramide catabolic process (GO:0046514) | 3.97107656 |
85 | drug catabolic process (GO:0042737) | 3.97071794 |
86 | positive regulation of leukocyte degranulation (GO:0043302) | 3.96362289 |
87 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.96135510 |
88 | serine family amino acid biosynthetic process (GO:0009070) | 3.94748772 |
89 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.89231154 |
90 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.88583720 |
91 | pinocytosis (GO:0006907) | 3.87178601 |
92 | aldehyde catabolic process (GO:0046185) | 3.86832045 |
93 | low-density lipoprotein particle remodeling (GO:0034374) | 3.85763914 |
94 | organic acid catabolic process (GO:0016054) | 3.85109301 |
95 | carboxylic acid catabolic process (GO:0046395) | 3.85109301 |
96 | ketone body metabolic process (GO:1902224) | 3.83364782 |
97 | positive regulation of lipid catabolic process (GO:0050996) | 3.82086883 |
98 | cholesterol efflux (GO:0033344) | 3.81864925 |
99 | neutrophil mediated immunity (GO:0002446) | 3.81135356 |
100 | negative regulation of interleukin-17 production (GO:0032700) | 3.80863329 |
101 | fatty acid beta-oxidation (GO:0006635) | 3.78512811 |
102 | urate metabolic process (GO:0046415) | 3.78309185 |
103 | drug transmembrane transport (GO:0006855) | 3.77327242 |
104 | arginine metabolic process (GO:0006525) | 3.76176606 |
105 | glucuronate metabolic process (GO:0019585) | 3.76156629 |
106 | uronic acid metabolic process (GO:0006063) | 3.76156629 |
107 | fatty acid oxidation (GO:0019395) | 3.75133166 |
108 | phospholipid homeostasis (GO:0055091) | 3.71267766 |
109 | positive regulation of B cell differentiation (GO:0045579) | 3.70465074 |
110 | valine metabolic process (GO:0006573) | 3.69489413 |
111 | lipid oxidation (GO:0034440) | 3.67948964 |
112 | plasma lipoprotein particle assembly (GO:0034377) | 3.67838784 |
113 | monocarboxylic acid catabolic process (GO:0072329) | 3.67483734 |
114 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.67200593 |
115 | cytolysis (GO:0019835) | 3.67017890 |
116 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.64712634 |
117 | 2-oxoglutarate metabolic process (GO:0006103) | 3.63812057 |
118 | amino sugar catabolic process (GO:0046348) | 3.62567515 |
119 | fibrinolysis (GO:0042730) | 3.62549145 |
120 | positive regulation of bone resorption (GO:0045780) | 3.61236612 |
121 | positive regulation of bone remodeling (GO:0046852) | 3.61236612 |
122 | fatty acid catabolic process (GO:0009062) | 3.60850733 |
123 | cholesterol homeostasis (GO:0042632) | 3.60417204 |
124 | regulation of cholesterol homeostasis (GO:2000188) | 3.60345488 |
125 | cofactor catabolic process (GO:0051187) | 3.58742622 |
126 | negative regulation of lipase activity (GO:0060192) | 3.57836543 |
127 | sterol homeostasis (GO:0055092) | 3.55540924 |
128 | complement activation (GO:0006956) | 3.55338749 |
129 | aspartate family amino acid catabolic process (GO:0009068) | 3.54699448 |
130 | negative regulation of interleukin-12 production (GO:0032695) | 3.54383494 |
131 | regulation of leukocyte degranulation (GO:0043300) | 3.54349666 |
132 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.50615953 |
133 | granulocyte activation (GO:0036230) | 3.45880591 |
134 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.43275549 |
135 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.41254536 |
136 | regulation of growth of symbiont in host (GO:0044126) | 3.41254536 |
137 | negative regulation of growth of symbiont in host (GO:0044130) | 3.41254536 |
138 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.41254536 |
139 | osteoclast differentiation (GO:0030316) | 3.36575131 |
140 | neutrophil activation (GO:0042119) | 3.33139995 |
141 | response to thyroid hormone (GO:0097066) | 3.28853966 |
142 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.26974121 |
143 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.23712248 |
144 | regulation of hypersensitivity (GO:0002883) | 3.21733720 |
145 | macrophage differentiation (GO:0030225) | 3.21599100 |
146 | detection of molecule of bacterial origin (GO:0032490) | 3.15108045 |
147 | respiratory burst (GO:0045730) | 3.14416191 |
148 | myeloid cell activation involved in immune response (GO:0002275) | 3.07928630 |
149 | adenosine receptor signaling pathway (GO:0001973) | 3.07235373 |
150 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.06669307 |
151 | positive regulation of regulated secretory pathway (GO:1903307) | 3.06202428 |
152 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03218721 |
153 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.02599141 |
154 | myeloid leukocyte mediated immunity (GO:0002444) | 3.01360867 |
155 | regulation of platelet activation (GO:0010543) | 3.01243050 |
156 | cellular response to ethanol (GO:0071361) | 3.00196731 |
157 | virion attachment to host cell (GO:0019062) | 2.99383533 |
158 | adhesion of symbiont to host cell (GO:0044650) | 2.99383533 |
159 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98643193 |
160 | immunoglobulin mediated immune response (GO:0016064) | 2.95978784 |
161 | regulation of gamma-delta T cell activation (GO:0046643) | 2.94499345 |
162 | granulocyte chemotaxis (GO:0071621) | 2.93400265 |
163 | peptide catabolic process (GO:0043171) | 2.93349178 |
164 | regulation of tolerance induction (GO:0002643) | 2.91569856 |
165 | granulocyte migration (GO:0097530) | 2.90990236 |
166 | regulation of cholesterol storage (GO:0010885) | 2.90354662 |
167 | histamine secretion (GO:0001821) | 2.86842930 |
168 | lipoxygenase pathway (GO:0019372) | 2.84527278 |
169 | germinal center formation (GO:0002467) | 2.83672603 |
170 | leukocyte degranulation (GO:0043299) | 2.83417749 |
171 | thrombin receptor signaling pathway (GO:0070493) | 2.83354889 |
172 | response to muramyl dipeptide (GO:0032495) | 2.82395155 |
173 | macrophage activation involved in immune response (GO:0002281) | 2.81803379 |
174 | adhesion of symbiont to host (GO:0044406) | 2.80230351 |
175 | regulation of regulated secretory pathway (GO:1903305) | 2.78956821 |
176 | detection of other organism (GO:0098543) | 2.78677746 |
177 | dendritic cell differentiation (GO:0097028) | 2.78550173 |
178 | positive regulation of macrophage differentiation (GO:0045651) | 2.78538768 |
179 | positive regulation of type 2 immune response (GO:0002830) | 2.77441752 |
180 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.77403626 |
181 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.76497869 |
182 | regulation of T cell tolerance induction (GO:0002664) | 2.75965589 |
183 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.75466091 |
184 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.75150666 |
185 | myeloid dendritic cell activation (GO:0001773) | 2.73915794 |
186 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.71691689 |
187 | purinergic receptor signaling pathway (GO:0035587) | 2.70705145 |
188 | positive regulation of antigen processing and presentation (GO:0002579) | 2.70310323 |
189 | regulation of monocyte differentiation (GO:0045655) | 2.68499311 |
190 | positive regulation by symbiont of host defense response (GO:0052509) | 2.66278854 |
191 | modulation by symbiont of host defense response (GO:0052031) | 2.66278854 |
192 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.66278854 |
193 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.66278854 |
194 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.66278854 |
195 | modulation by symbiont of host immune response (GO:0052553) | 2.66278854 |
196 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.65659949 |
197 | detection of external biotic stimulus (GO:0098581) | 2.65243135 |
198 | regulation of integrin activation (GO:0033623) | 2.64568518 |
199 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.64515956 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.19065772 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.03008637 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.72727022 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.38220568 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.01902305 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.05560862 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.72616194 |
8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.36152919 |
9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.13873707 |
10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.08968387 |
11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.96154060 |
12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.89460906 |
13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.83617275 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.75829386 |
15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.72467585 |
16 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.43693030 |
17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.29392676 |
18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.69683690 |
19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.62442486 |
20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.54536352 |
21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.53098079 |
22 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.50997340 |
23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.49939915 |
24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.48014053 |
25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.42535327 |
26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.34349620 |
27 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17296776 |
28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11630664 |
29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06703328 |
30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.03831638 |
31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.00000854 |
32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4033654 |
33 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97982783 |
34 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.97372261 |
35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.96101851 |
36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.92997021 |
37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.92944619 |
38 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.92538302 |
39 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86944449 |
40 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.83248545 |
41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.77474331 |
42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76889736 |
43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.74428480 |
44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.72896629 |
45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.72712242 |
46 | MYB_26560356_Chip-Seq_TH2_Human | 1.72655558 |
47 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.71903153 |
48 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.71036409 |
49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.62901843 |
50 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.62208979 |
51 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.60604143 |
52 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60222616 |
53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.52443425 |
54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.51770276 |
55 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.51138797 |
56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49006264 |
57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46547748 |
58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44274443 |
59 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.42497593 |
60 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40390319 |
61 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39915437 |
62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38314859 |
63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.34436244 |
64 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.30564538 |
65 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.27943234 |
66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24752661 |
67 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24375015 |
68 | MYB_26560356_Chip-Seq_TH1_Human | 1.24141984 |
69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20938761 |
70 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19601959 |
71 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17884917 |
72 | MAF_26560356_Chip-Seq_TH1_Human | 1.17256671 |
73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16962433 |
74 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.15419620 |
75 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14679647 |
76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13971232 |
77 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13661483 |
78 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13241664 |
79 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12694300 |
80 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08178244 |
81 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07145156 |
82 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06574706 |
83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05323262 |
84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02869290 |
85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01999274 |
86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01090824 |
87 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98666924 |
88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98044219 |
89 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97993649 |
90 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93282573 |
91 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92894717 |
92 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90899307 |
93 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90653679 |
94 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90498473 |
95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90130332 |
96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89784530 |
97 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88284125 |
98 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87289791 |
99 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86976850 |
100 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.86712365 |
101 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85683263 |
102 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84482315 |
103 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.84253180 |
104 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.84099503 |
105 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83279516 |
106 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82801980 |
107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81223652 |
108 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79977008 |
109 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78958475 |
110 | MYC_22102868_ChIP-Seq_BL_Human | 0.78129522 |
111 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.77764102 |
112 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76955913 |
113 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.76619260 |
114 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.76260034 |
115 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.75727176 |
116 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75102805 |
117 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.74929433 |
118 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74700831 |
119 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.72492685 |
120 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72115411 |
121 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72115411 |
122 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71685650 |
123 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.71617406 |
124 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.70490844 |
125 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.70429622 |
126 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70254372 |
127 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.67804701 |
128 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.67325042 |
129 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.67085870 |
130 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66281608 |
131 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65306712 |
132 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63761796 |
133 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.63545159 |
134 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62381923 |
135 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61521260 |
136 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61398429 |
137 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.59426704 |
138 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59233492 |
139 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.58023150 |
140 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.57563308 |
141 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.56329683 |
142 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53719866 |
143 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53567725 |
144 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53283365 |
145 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53177875 |
146 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52877366 |
147 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52693303 |
148 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.52025007 |
149 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51852711 |
150 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50885125 |
151 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.50348536 |
152 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50328631 |
153 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.49922251 |
154 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49423661 |
155 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.48238727 |
156 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.47038657 |
157 | GATA1_19941826_ChIP-Seq_K562_Human | 0.46986049 |
158 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.45872956 |
159 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44980830 |
160 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44390610 |
161 | GATA2_19941826_ChIP-Seq_K562_Human | 0.44325260 |
162 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.43210040 |
163 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42834745 |
164 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41889073 |
165 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41313099 |
166 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.40743803 |
167 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.40418847 |
168 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40372908 |
169 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.39979399 |
170 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.39802250 |
171 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39757855 |
172 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.39656742 |
173 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.38586877 |
174 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.38317066 |
175 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.37546093 |
176 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.36941071 |
177 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36705749 |
178 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36252478 |
179 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.35566297 |
180 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.35499769 |
181 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.35297138 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.26509132 |
2 | MP0005360_urolithiasis | 7.61882926 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.14696868 |
4 | MP0005365_abnormal_bile_salt | 6.07314283 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.85490902 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.09775235 |
7 | MP0003252_abnormal_bile_duct | 3.82888876 |
8 | MP0010329_abnormal_lipoprotein_level | 3.66662355 |
9 | MP0003303_peritoneal_inflammation | 3.29901635 |
10 | MP0003172_abnormal_lysosome_physiology | 3.21219692 |
11 | MP0001835_abnormal_antigen_presentation | 2.99492911 |
12 | MP0009840_abnormal_foam_cell | 2.93559500 |
13 | MP0005332_abnormal_amino_acid | 2.87852486 |
14 | MP0002419_abnormal_innate_immunity | 2.87812440 |
15 | MP0002148_abnormal_hypersensitivity_rea | 2.82427192 |
16 | MP0005083_abnormal_biliary_tract | 2.78110648 |
17 | MP0003195_calcinosis | 2.74444767 |
18 | * MP0005671_abnormal_response_to | 2.57605601 |
19 | MP0002877_abnormal_melanocyte_morpholog | 2.55140695 |
20 | MP0001666_abnormal_nutrient_absorption | 2.50893689 |
21 | MP0000343_altered_response_to | 2.49848084 |
22 | MP0003300_gastrointestinal_ulcer | 2.29926718 |
23 | MP0005025_abnormal_response_to | 2.29239667 |
24 | MP0004019_abnormal_vitamin_homeostasis | 2.26868475 |
25 | MP0003191_abnormal_cellular_cholesterol | 2.26138094 |
26 | MP0002118_abnormal_lipid_homeostasis | 2.21726949 |
27 | MP0005000_abnormal_immune_tolerance | 2.19808278 |
28 | MP0000609_abnormal_liver_physiology | 2.16217406 |
29 | MP0001545_abnormal_hematopoietic_system | 2.14998034 |
30 | MP0005397_hematopoietic_system_phenotyp | 2.14998034 |
31 | * MP0002452_abnormal_antigen_presenting | 2.11856347 |
32 | MP0000569_abnormal_digit_pigmentation | 2.09355347 |
33 | MP0005387_immune_system_phenotype | 2.08794410 |
34 | MP0001790_abnormal_immune_system | 2.08794410 |
35 | MP0009785_altered_susceptibility_to | 2.08309698 |
36 | MP0009278_abnormal_bone_marrow | 2.05451005 |
37 | MP0008004_abnormal_stomach_pH | 1.96881639 |
38 | MP0002138_abnormal_hepatobiliary_system | 1.93965768 |
39 | * MP0002723_abnormal_immune_serum | 1.88437859 |
40 | MP0000685_abnormal_immune_system | 1.86449544 |
41 | MP0004947_skin_inflammation | 1.83694578 |
42 | MP0001800_abnormal_humoral_immune | 1.81743143 |
43 | MP0002998_abnormal_bone_remodeling | 1.80442885 |
44 | * MP0001819_abnormal_immune_cell | 1.80000783 |
45 | * MP0002420_abnormal_adaptive_immunity | 1.79784396 |
46 | MP0003868_abnormal_feces_composition | 1.79276081 |
47 | * MP0005319_abnormal_enzyme/_coenzyme | 1.78053924 |
48 | MP0001533_abnormal_skeleton_physiology | 1.77236668 |
49 | MP0001764_abnormal_homeostasis | 1.73616054 |
50 | MP0001845_abnormal_inflammatory_respons | 1.64550882 |
51 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.62328719 |
52 | MP0000015_abnormal_ear_pigmentation | 1.60910354 |
53 | MP0002405_respiratory_system_inflammati | 1.56984182 |
54 | MP0005670_abnormal_white_adipose | 1.52471591 |
55 | MP0003828_pulmonary_edema | 1.46679411 |
56 | MP0003186_abnormal_redox_activity | 1.46528010 |
57 | MP0009697_abnormal_copulation | 1.44391061 |
58 | MP0009643_abnormal_urine_homeostasis | 1.43968874 |
59 | * MP0000716_abnormal_immune_system | 1.37677389 |
60 | MP0005167_abnormal_blood-brain_barrier | 1.36090782 |
61 | MP0000465_gastrointestinal_hemorrhage | 1.35144625 |
62 | MP0003448_altered_tumor_morphology | 1.34742556 |
63 | * MP0002398_abnormal_bone_marrow | 1.32648313 |
64 | MP0005451_abnormal_body_composition | 1.31568129 |
65 | MP0003183_abnormal_peptide_metabolism | 1.25134753 |
66 | MP0003705_abnormal_hypodermis_morpholog | 1.24980723 |
67 | MP0010155_abnormal_intestine_physiology | 1.24173674 |
68 | MP0002876_abnormal_thyroid_physiology | 1.22380449 |
69 | MP0000858_altered_metastatic_potential | 1.21352600 |
70 | MP0004808_abnormal_hematopoietic_stem | 1.20433067 |
71 | MP0003011_delayed_dark_adaptation | 1.20282941 |
72 | MP0008260_abnormal_autophagy | 1.18960947 |
73 | MP0000689_abnormal_spleen_morphology | 1.18562344 |
74 | * MP0002429_abnormal_blood_cell | 1.16886089 |
75 | MP0003091_abnormal_cell_migration | 1.16666174 |
76 | MP0002396_abnormal_hematopoietic_system | 1.16283058 |
77 | MP0004130_abnormal_muscle_cell | 1.15320418 |
78 | MP0000598_abnormal_liver_morphology | 1.13824668 |
79 | MP0005647_abnormal_sex_gland | 1.13686232 |
80 | MP0001851_eye_inflammation | 1.10815850 |
81 | MP0002722_abnormal_immune_system | 1.08937789 |
82 | MP0009333_abnormal_splenocyte_physiolog | 1.08366369 |
83 | MP0005174_abnormal_tail_pigmentation | 1.06171599 |
84 | MP0003656_abnormal_erythrocyte_physiolo | 1.05126486 |
85 | MP0009764_decreased_sensitivity_to | 1.02527767 |
86 | MP0005636_abnormal_mineral_homeostasis | 0.99721989 |
87 | MP0005666_abnormal_adipose_tissue | 0.98022227 |
88 | MP0009763_increased_sensitivity_to | 0.98012548 |
89 | MP0000604_amyloidosis | 0.97586631 |
90 | MP0000371_diluted_coat_color | 0.97561826 |
91 | MP0002254_reproductive_system_inflammat | 0.96797017 |
92 | MP0002971_abnormal_brown_adipose | 0.96305235 |
93 | MP0004510_myositis | 0.95864493 |
94 | MP0005334_abnormal_fat_pad | 0.93703848 |
95 | MP0001958_emphysema | 0.92897094 |
96 | MP0005310_abnormal_salivary_gland | 0.92690630 |
97 | MP0006036_abnormal_mitochondrial_physio | 0.92053796 |
98 | MP0000920_abnormal_myelination | 0.91314596 |
99 | MP0005535_abnormal_body_temperature | 0.88175794 |
100 | MP0003795_abnormal_bone_structure | 0.87615269 |
101 | MP0002078_abnormal_glucose_homeostasis | 0.86445132 |
102 | MP0003279_aneurysm | 0.86314342 |
103 | MP0004883_abnormal_blood_vessel | 0.85625804 |
104 | * MP0009642_abnormal_blood_homeostasis | 0.85613001 |
105 | MP0001661_extended_life_span | 0.85178237 |
106 | MP0003566_abnormal_cell_adhesion | 0.82147956 |
107 | MP0003690_abnormal_glial_cell | 0.82141818 |
108 | * MP0008469_abnormal_protein_level | 0.81996625 |
109 | MP0005084_abnormal_gallbladder_morpholo | 0.81062910 |
110 | MP0010368_abnormal_lymphatic_system | 0.80649060 |
111 | MP0005390_skeleton_phenotype | 0.80505607 |
112 | MP0001756_abnormal_urination | 0.78818058 |
113 | MP0005376_homeostasis/metabolism_phenot | 0.77867453 |
114 | MP0005408_hypopigmentation | 0.75009518 |
115 | MP0002837_dystrophic_cardiac_calcinosis | 0.73931732 |
116 | MP0009765_abnormal_xenobiotic_induced | 0.73924703 |
117 | MP0010386_abnormal_urinary_bladder | 0.72411613 |
118 | MP0010307_abnormal_tumor_latency | 0.70894691 |
119 | MP0003453_abnormal_keratinocyte_physiol | 0.67322544 |
120 | MP0005448_abnormal_energy_balance | 0.67017161 |
121 | MP0005220_abnormal_exocrine_pancreas | 0.65640207 |
122 | MP0005165_increased_susceptibility_to | 0.64665174 |
123 | MP0005266_abnormal_metabolism | 0.64513562 |
124 | MP0008438_abnormal_cutaneous_collagen | 0.64378233 |
125 | MP0005023_abnormal_wound_healing | 0.61428477 |
126 | MP0009115_abnormal_fat_cell | 0.60805167 |
127 | MP0003329_amyloid_beta_deposits | 0.60678684 |
128 | MP0002166_altered_tumor_susceptibility | 0.60013708 |
129 | * MP0002136_abnormal_kidney_physiology | 0.56959847 |
130 | MP0003724_increased_susceptibility_to | 0.56462181 |
131 | MP0006035_abnormal_mitochondrial_morpho | 0.52010995 |
132 | MP0009053_abnormal_anal_canal | 0.51512601 |
133 | MP0004185_abnormal_adipocyte_glucose | 0.51323600 |
134 | MP0002970_abnormal_white_adipose | 0.50020871 |
135 | MP0005375_adipose_tissue_phenotype | 0.49804814 |
136 | MP0000639_abnormal_adrenal_gland | 0.49333780 |
137 | MP0003953_abnormal_hormone_level | 0.48275850 |
138 | MP0002928_abnormal_bile_duct | 0.46300531 |
139 | MP0002796_impaired_skin_barrier | 0.45874541 |
140 | MP0004043_abnormal_pH_regulation | 0.45421326 |
141 | MP0005395_other_phenotype | 0.45324320 |
142 | MP0003638_abnormal_response/metabolism_ | 0.44665094 |
143 | MP0003959_abnormal_lean_body | 0.43049086 |
144 | MP0008874_decreased_physiological_sensi | 0.42207663 |
145 | MP0002168_other_aberrant_phenotype | 0.41532658 |
146 | MP0009672_abnormal_birth_weight | 0.41499453 |
147 | MP0004782_abnormal_surfactant_physiolog | 0.41236963 |
148 | MP0000230_abnormal_systemic_arterial | 0.41226451 |
149 | MP0003075_altered_response_to | 0.40918890 |
150 | MP0005058_abnormal_lysosome_morphology | 0.38311260 |
151 | MP0005464_abnormal_platelet_physiology | 0.37976433 |
152 | MP0008873_increased_physiological_sensi | 0.37906901 |
153 | MP0001881_abnormal_mammary_gland | 0.37046273 |
154 | MP0008872_abnormal_physiological_respon | 0.34637685 |
155 | MP0002822_catalepsy | 0.33888484 |
156 | MP0003436_decreased_susceptibility_to | 0.33867101 |
157 | MP0005166_decreased_susceptibility_to | 0.32723534 |
158 | MP0004381_abnormal_hair_follicle | 0.32593892 |
159 | MP0000249_abnormal_blood_vessel | 0.32396622 |
160 | MP0001765_abnormal_ion_homeostasis | 0.32027251 |
161 | MP0005248_abnormal_Harderian_gland | 0.31657525 |
162 | MP0001853_heart_inflammation | 0.31622132 |
163 | MP0003718_maternal_effect | 0.29172252 |
164 | MP0002060_abnormal_skin_morphology | 0.28410861 |
165 | MP0005164_abnormal_response_to | 0.27515546 |
166 | MP0005452_abnormal_adipose_tissue | 0.27512583 |
167 | MP0006082_CNS_inflammation | 0.26716095 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 7.08725721 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.00378545 |
3 | Vacuolated lymphocytes (HP:0001922) | 6.92645390 |
4 | Deep venous thrombosis (HP:0002625) | 6.89115301 |
5 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.22195809 |
6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.22195809 |
7 | Abnormality of glycolipid metabolism (HP:0010969) | 6.22195809 |
8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.20491889 |
9 | Xanthomatosis (HP:0000991) | 6.15370524 |
10 | Prolonged partial thromboplastin time (HP:0003645) | 5.96537542 |
11 | Hypobetalipoproteinemia (HP:0003563) | 5.91600463 |
12 | Hyperlipoproteinemia (HP:0010980) | 5.28535220 |
13 | Complement deficiency (HP:0004431) | 5.25899288 |
14 | Recurrent bacterial skin infections (HP:0005406) | 5.09724752 |
15 | Abnormality of macrophages (HP:0004311) | 5.03359328 |
16 | Recurrent abscess formation (HP:0002722) | 4.94658028 |
17 | Dysostosis multiplex (HP:0000943) | 4.73569424 |
18 | Hyperglycinemia (HP:0002154) | 4.71456397 |
19 | Hyperammonemia (HP:0001987) | 4.66327353 |
20 | Hyperglycinuria (HP:0003108) | 4.56555808 |
21 | Ketosis (HP:0001946) | 4.51800706 |
22 | Hypolipoproteinemia (HP:0010981) | 4.50752360 |
23 | Epidermoid cyst (HP:0200040) | 4.46958589 |
24 | Abnormality of glycine metabolism (HP:0010895) | 4.41203375 |
25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.41203375 |
26 | Joint hemorrhage (HP:0005261) | 4.39250217 |
27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.33384326 |
28 | Spontaneous hematomas (HP:0007420) | 4.23073327 |
29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.19367575 |
30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.10444581 |
31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.04372354 |
32 | Fat malabsorption (HP:0002630) | 4.01451375 |
33 | Hypoalphalipoproteinemia (HP:0003233) | 3.99701088 |
34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.97911265 |
35 | Increased cerebral lipofuscin (HP:0011813) | 3.97060465 |
36 | Hypoglycemic coma (HP:0001325) | 3.95712728 |
37 | Abnormality of methionine metabolism (HP:0010901) | 3.89592997 |
38 | Abnormality of complement system (HP:0005339) | 3.81098435 |
39 | Eczematoid dermatitis (HP:0000976) | 3.72713820 |
40 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.62233463 |
41 | Purpura (HP:0000979) | 3.61602008 |
42 | Petechiae (HP:0000967) | 3.61258616 |
43 | Hypercholesterolemia (HP:0003124) | 3.54029480 |
44 | Conjugated hyperbilirubinemia (HP:0002908) | 3.51125110 |
45 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.50226650 |
46 | Prolonged bleeding time (HP:0003010) | 3.50136475 |
47 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.49195533 |
48 | Abnormality of the intrinsic pathway (HP:0010989) | 3.48903497 |
49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.46603178 |
50 | Ketoacidosis (HP:0001993) | 3.43505954 |
51 | Epistaxis (HP:0000421) | 3.33768013 |
52 | Delayed CNS myelination (HP:0002188) | 3.23701832 |
53 | Hyperbilirubinemia (HP:0002904) | 3.22273711 |
54 | Abnormality of nucleobase metabolism (HP:0010932) | 3.19956909 |
55 | Loss of speech (HP:0002371) | 3.19725188 |
56 | Abnormality of serum amino acid levels (HP:0003112) | 3.16808259 |
57 | Recurrent skin infections (HP:0001581) | 3.11148697 |
58 | Abnormal platelet volume (HP:0011876) | 3.09786155 |
59 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.08961467 |
60 | Mucopolysacchariduria (HP:0008155) | 3.08961467 |
61 | Disinhibition (HP:0000734) | 3.08545329 |
62 | Increased mean platelet volume (HP:0011877) | 3.06999719 |
63 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.06003084 |
64 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.06003084 |
65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.06003084 |
66 | Abnormality of purine metabolism (HP:0004352) | 3.04822039 |
67 | Steatorrhea (HP:0002570) | 3.04702975 |
68 | Hepatosplenomegaly (HP:0001433) | 3.01146737 |
69 | Myocardial infarction (HP:0001658) | 2.98930296 |
70 | Axonal loss (HP:0003447) | 2.91469470 |
71 | Hepatocellular carcinoma (HP:0001402) | 2.91271828 |
72 | Metabolic acidosis (HP:0001942) | 2.86164043 |
73 | Gingival bleeding (HP:0000225) | 2.84430072 |
74 | Gout (HP:0001997) | 2.83841516 |
75 | Dicarboxylic aciduria (HP:0003215) | 2.82558496 |
76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.82558496 |
77 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.82228832 |
78 | Skin nodule (HP:0200036) | 2.77453552 |
79 | Upper motor neuron abnormality (HP:0002127) | 2.75723701 |
80 | Agnosia (HP:0010524) | 2.73070598 |
81 | Systemic lupus erythematosus (HP:0002725) | 2.71929754 |
82 | Lethargy (HP:0001254) | 2.71407699 |
83 | Chronic obstructive pulmonary disease (HP:0006510) | 2.71046385 |
84 | Obstructive lung disease (HP:0006536) | 2.71046385 |
85 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.65616246 |
86 | Osteolytic defects of the hand bones (HP:0009699) | 2.65362050 |
87 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.65362050 |
88 | Vascular calcification (HP:0004934) | 2.63448504 |
89 | Hypochromic microcytic anemia (HP:0004840) | 2.60802498 |
90 | Tetraparesis (HP:0002273) | 2.60719908 |
91 | Spondylolisthesis (HP:0003302) | 2.56165040 |
92 | Gingivitis (HP:0000230) | 2.55710513 |
93 | Spastic diplegia (HP:0001264) | 2.50122414 |
94 | Generalized aminoaciduria (HP:0002909) | 2.45539529 |
95 | Autoimmune thrombocytopenia (HP:0001973) | 2.44207864 |
96 | Hypoglycemic seizures (HP:0002173) | 2.43740587 |
97 | Abnormal platelet function (HP:0011869) | 2.43055191 |
98 | Impaired platelet aggregation (HP:0003540) | 2.43055191 |
99 | Cerebral edema (HP:0002181) | 2.42472533 |
100 | Mediastinal lymphadenopathy (HP:0100721) | 2.40857221 |
101 | Recurrent fungal infections (HP:0002841) | 2.39670602 |
102 | Spontaneous abortion (HP:0005268) | 2.38810373 |
103 | Abnormal gallbladder morphology (HP:0012437) | 2.38265042 |
104 | Neonatal onset (HP:0003623) | 2.36640031 |
105 | Cardiovascular calcification (HP:0011915) | 2.36511435 |
106 | Abnormality of the prostate (HP:0008775) | 2.35503670 |
107 | Irritability (HP:0000737) | 2.35021069 |
108 | Acanthocytosis (HP:0001927) | 2.34549608 |
109 | Malnutrition (HP:0004395) | 2.32432835 |
110 | Mitral stenosis (HP:0001718) | 2.31656156 |
111 | Cholelithiasis (HP:0001081) | 2.31208361 |
112 | Pancreatitis (HP:0001733) | 2.30719616 |
113 | Mutism (HP:0002300) | 2.29433726 |
114 | Sensorimotor neuropathy (HP:0007141) | 2.27314975 |
115 | Pustule (HP:0200039) | 2.25759513 |
116 | Asymmetric septal hypertrophy (HP:0001670) | 2.24495846 |
117 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.24077775 |
118 | Recurrent cutaneous fungal infections (HP:0011370) | 2.24077775 |
119 | Conjunctival telangiectasia (HP:0000524) | 2.23871685 |
120 | Premature loss of primary teeth (HP:0006323) | 2.23633294 |
121 | Hydroxyprolinuria (HP:0003080) | 2.23145774 |
122 | Abnormality of proline metabolism (HP:0010907) | 2.23145774 |
123 | Vomiting (HP:0002013) | 2.22140789 |
124 | Cholecystitis (HP:0001082) | 2.21948972 |
125 | Abnormal gallbladder physiology (HP:0012438) | 2.21948972 |
126 | Bone pain (HP:0002653) | 2.21848862 |
127 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.20409200 |
128 | Late onset (HP:0003584) | 2.19305733 |
129 | Protuberant abdomen (HP:0001538) | 2.18416602 |
130 | Meningitis (HP:0001287) | 2.16990106 |
131 | Recurrent viral infections (HP:0004429) | 2.15653927 |
132 | Hemorrhage of the eye (HP:0011885) | 2.15424955 |
133 | Pathologic fracture (HP:0002756) | 2.15354464 |
134 | Glomerulonephritis (HP:0000099) | 2.14848898 |
135 | Brushfield spots (HP:0001088) | 2.14678982 |
136 | Enlarged kidneys (HP:0000105) | 2.14067993 |
137 | Interstitial pulmonary disease (HP:0006530) | 2.13273654 |
138 | Periodontitis (HP:0000704) | 2.12683824 |
139 | Proximal tubulopathy (HP:0000114) | 2.12594182 |
140 | Stomatitis (HP:0010280) | 2.11469844 |
141 | Thick nail (HP:0001805) | 2.10738449 |
142 | Esophageal varix (HP:0002040) | 2.10626722 |
143 | Amaurosis fugax (HP:0100576) | 2.09465840 |
144 | T lymphocytopenia (HP:0005403) | 2.08233969 |
145 | Hyperuricemia (HP:0002149) | 2.06570549 |
146 | Increased purine levels (HP:0004368) | 2.06570549 |
147 | Abnormal cartilage morphology (HP:0002763) | 2.06312985 |
148 | Amyloidosis (HP:0011034) | 2.06040938 |
149 | Rickets (HP:0002748) | 2.03812864 |
150 | Alkalosis (HP:0001948) | 2.03734393 |
151 | Hypertriglyceridemia (HP:0002155) | 2.03222981 |
152 | Cellulitis (HP:0100658) | 2.03073835 |
153 | Myositis (HP:0100614) | 2.02497547 |
154 | Increased serum ferritin (HP:0003281) | 2.02482255 |
155 | Opisthotonus (HP:0002179) | 2.01119891 |
156 | Basal ganglia calcification (HP:0002135) | 1.99742681 |
157 | Hematochezia (HP:0002573) | 1.98757863 |
158 | Diminished motivation (HP:0000745) | 1.97102630 |
159 | Abnormality of the gallbladder (HP:0005264) | 1.96140894 |
160 | Progressive neurologic deterioration (HP:0002344) | 1.96047173 |
161 | Metaphyseal irregularity (HP:0003025) | 1.95711182 |
162 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.95378562 |
163 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.95282631 |
164 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93999205 |
165 | Osteomyelitis (HP:0002754) | 1.93716067 |
166 | Apathy (HP:0000741) | 1.91788915 |
167 | Neurofibrillary tangles (HP:0002185) | 1.91704709 |
168 | Menorrhagia (HP:0000132) | 1.90604676 |
169 | Renal cortical cysts (HP:0000803) | 1.90592050 |
170 | Abnormality of urine glucose concentration (HP:0011016) | 1.89998969 |
171 | Glycosuria (HP:0003076) | 1.89998969 |
172 | Abnormality of iron homeostasis (HP:0011031) | 1.89207728 |
173 | Thin bony cortex (HP:0002753) | 1.88999520 |
174 | Thrombocytosis (HP:0001894) | 1.87832151 |
175 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.87652390 |
176 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.85489877 |
177 | Thoracic kyphosis (HP:0002942) | 1.84842122 |
178 | Vertebral compression fractures (HP:0002953) | 1.84519502 |
179 | Orchitis (HP:0100796) | 1.83667701 |
180 | Elevated hepatic transaminases (HP:0002910) | 1.82787194 |
181 | Thrombophlebitis (HP:0004418) | 1.82172685 |
182 | Hypophosphatemic rickets (HP:0004912) | 1.80277720 |
183 | Nausea (HP:0002018) | 1.79956909 |
184 | Abnormality of T cell number (HP:0011839) | 1.79436659 |
185 | Albinism (HP:0001022) | 1.79121418 |
186 | Abnormality of vitamin metabolism (HP:0100508) | 1.78096865 |
187 | Retrobulbar optic neuritis (HP:0100654) | 1.77942450 |
188 | Optic neuritis (HP:0100653) | 1.77942450 |
189 | Distal lower limb amyotrophy (HP:0008944) | 1.77836570 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.23332875 |
2 | SIK1 | 4.94432486 |
3 | FGFR4 | 4.06091200 |
4 | RIPK4 | 4.02379892 |
5 | ERN1 | 3.98166793 |
6 | BLK | 3.70188554 |
7 | INSRR | 2.84481570 |
8 | TAOK3 | 2.65693885 |
9 | TRIB3 | 2.46158520 |
10 | SCYL2 | 2.44054593 |
11 | MST1R | 2.43471818 |
12 | TTN | 2.41496525 |
13 | ZAP70 | 2.38763390 |
14 | ERBB4 | 2.38012393 |
15 | TEC | 2.21898711 |
16 | PKN2 | 2.14839119 |
17 | MAP2K4 | 2.02542300 |
18 | GRK7 | 1.90971263 |
19 | KIT | 1.90546849 |
20 | PIK3CG | 1.87935645 |
21 | SYK | 1.87728773 |
22 | BTK | 1.87080107 |
23 | PRPF4B | 1.80584774 |
24 | CAMK1D | 1.79179248 |
25 | FLT3 | 1.78292439 |
26 | TRPM7 | 1.74761587 |
27 | CAMKK2 | 1.74326134 |
28 | MAPK11 | 1.72885147 |
29 | FRK | 1.71299154 |
30 | FES | 1.61571070 |
31 | LATS1 | 1.61515019 |
32 | MATK | 1.59390051 |
33 | BMPR2 | 1.52893176 |
34 | FGFR2 | 1.52020453 |
35 | JAK3 | 1.49252849 |
36 | TYK2 | 1.42243753 |
37 | DAPK2 | 1.41736448 |
38 | ABL2 | 1.38852423 |
39 | PRKAA2 | 1.37528799 |
40 | FGR | 1.33960116 |
41 | NEK9 | 1.32608225 |
42 | PTK6 | 1.31898936 |
43 | LYN | 1.28050277 |
44 | HCK | 1.25649996 |
45 | MAP4K1 | 1.19690945 |
46 | JAK2 | 1.17652529 |
47 | MAP3K7 | 1.16826083 |
48 | IRAK4 | 1.16761556 |
49 | PINK1 | 1.16748367 |
50 | KDR | 1.11063440 |
51 | CAMK1G | 1.10503929 |
52 | MOS | 1.07712407 |
53 | TESK2 | 1.04251216 |
54 | MAP2K3 | 1.03159931 |
55 | IKBKB | 1.03088790 |
56 | STK38L | 1.02237437 |
57 | EEF2K | 1.01551732 |
58 | ITK | 1.01417717 |
59 | JAK1 | 0.98907633 |
60 | RIPK1 | 0.96653016 |
61 | PDK3 | 0.95468107 |
62 | PDK4 | 0.95468107 |
63 | MET | 0.94788093 |
64 | TIE1 | 0.91552501 |
65 | CDK6 | 0.91247387 |
66 | ACVR1B | 0.90316313 |
67 | TXK | 0.90156202 |
68 | GRK6 | 0.89825182 |
69 | LCK | 0.87712646 |
70 | TBK1 | 0.87169018 |
71 | PRKCZ | 0.86168022 |
72 | MAP3K10 | 0.86112986 |
73 | NME2 | 0.84614947 |
74 | MAPK4 | 0.83334029 |
75 | ADRBK2 | 0.82841569 |
76 | MAP3K14 | 0.82093931 |
77 | PRKAA1 | 0.79754897 |
78 | MAP3K3 | 0.78975558 |
79 | PIM2 | 0.78793099 |
80 | DDR2 | 0.78587978 |
81 | PRKACG | 0.77938809 |
82 | IRAK3 | 0.77690445 |
83 | RPS6KA2 | 0.76940847 |
84 | GSK3A | 0.76665916 |
85 | ERBB2 | 0.76431032 |
86 | MAPKAPK3 | 0.76053925 |
87 | MAP3K1 | 0.74656882 |
88 | CSK | 0.73222761 |
89 | MAPK12 | 0.72948224 |
90 | FGFR3 | 0.72529351 |
91 | BMX | 0.71581778 |
92 | WNK4 | 0.70241158 |
93 | MAP3K2 | 0.69998808 |
94 | TGFBR2 | 0.67217870 |
95 | MAPK15 | 0.66946208 |
96 | EPHB1 | 0.66896747 |
97 | SGK3 | 0.66708423 |
98 | CDC42BPA | 0.65084993 |
99 | MARK3 | 0.63721616 |
100 | DYRK1B | 0.63333976 |
101 | PDPK1 | 0.62963009 |
102 | MAP3K11 | 0.54907702 |
103 | CAMK2G | 0.54382489 |
104 | MAP2K1 | 0.54318285 |
105 | PTK2 | 0.53549327 |
106 | CSF1R | 0.52667059 |
107 | WNK3 | 0.52010211 |
108 | IGF1R | 0.51477836 |
109 | MAP3K6 | 0.50905243 |
110 | MAP2K6 | 0.50373614 |
111 | STK24 | 0.48749515 |
112 | SGK494 | 0.48697252 |
113 | SGK223 | 0.48697252 |
114 | RPS6KC1 | 0.47990547 |
115 | RPS6KL1 | 0.47990547 |
116 | TNK2 | 0.47466263 |
117 | CSNK1G1 | 0.46139079 |
118 | SGK2 | 0.45810851 |
119 | ABL1 | 0.45351856 |
120 | YES1 | 0.45177922 |
121 | PIK3CA | 0.44358374 |
122 | RET | 0.44091524 |
123 | PDK1 | 0.43498377 |
124 | PRKCQ | 0.42615009 |
125 | PIM1 | 0.41774826 |
126 | STK10 | 0.40502464 |
127 | KSR2 | 0.40278507 |
128 | PDK2 | 0.40156653 |
129 | CAMKK1 | 0.39915198 |
130 | EPHA3 | 0.39523479 |
131 | MTOR | 0.39522120 |
132 | PDGFRB | 0.39017161 |
133 | CDK4 | 0.38607924 |
134 | MAPK7 | 0.38189160 |
135 | OXSR1 | 0.37258330 |
136 | ARAF | 0.36815447 |
137 | FYN | 0.35026482 |
138 | EIF2AK3 | 0.34952309 |
139 | IKBKE | 0.34624028 |
140 | ICK | 0.34140838 |
141 | RPS6KA6 | 0.33974433 |
142 | IRAK1 | 0.33794922 |
143 | IRAK2 | 0.32589833 |
144 | GRK1 | 0.32388413 |
145 | PAK1 | 0.31898327 |
146 | PDGFRA | 0.31284097 |
147 | MAP3K5 | 0.29007737 |
148 | MAP3K13 | 0.28803975 |
149 | LATS2 | 0.27155174 |
150 | TAOK2 | 0.27026235 |
151 | EGFR | 0.26128322 |
152 | EPHA4 | 0.25698040 |
153 | EPHB2 | 0.25045034 |
154 | PRKCG | 0.24464180 |
155 | PKN1 | 0.23697273 |
156 | PRKCH | 0.23520584 |
157 | FGFR1 | 0.23025485 |
158 | PRKCA | 0.22822809 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.35579037 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 4.00272322 |
3 | Lysosome_Homo sapiens_hsa04142 | 3.64336053 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36105818 |
5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.33161217 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.05336870 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.85557979 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.73722659 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68968736 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68310422 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.63367664 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.60379046 |
13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.51459735 |
14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.50794140 |
15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.49516143 |
16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.48249607 |
17 | Asthma_Homo sapiens_hsa05310 | 2.44977138 |
18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.32948058 |
19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.31067318 |
20 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.26926182 |
21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.24127695 |
22 | Peroxisome_Homo sapiens_hsa04146 | 2.18427806 |
23 | Phagosome_Homo sapiens_hsa04145 | 2.16190249 |
24 | Tuberculosis_Homo sapiens_hsa05152 | 2.13698342 |
25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.12175944 |
26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10779306 |
27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.08188256 |
28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.02116909 |
29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.98507427 |
30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88233828 |
31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87276089 |
32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84145367 |
33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83420174 |
34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82850469 |
35 | Platelet activation_Homo sapiens_hsa04611 | 1.81311158 |
36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.71641306 |
37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69890355 |
38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68731364 |
39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68153875 |
40 | Allograft rejection_Homo sapiens_hsa05330 | 1.67177102 |
41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65141388 |
42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64961604 |
43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63494784 |
44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62744956 |
45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60543515 |
46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56852246 |
47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.56495589 |
48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.55475022 |
49 | Malaria_Homo sapiens_hsa05144 | 1.54307480 |
50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.53439302 |
51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50940595 |
52 | Bile secretion_Homo sapiens_hsa04976 | 1.48317968 |
53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.47589889 |
54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.45868997 |
55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44675423 |
56 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40963497 |
57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.40664362 |
58 | Pertussis_Homo sapiens_hsa05133 | 1.38348175 |
59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.37400216 |
60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.36876319 |
61 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35956276 |
62 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.35032130 |
63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.34312574 |
64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33041958 |
65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31653724 |
66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29311059 |
67 | Legionellosis_Homo sapiens_hsa05134 | 1.28411440 |
68 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24532858 |
69 | Carbon metabolism_Homo sapiens_hsa01200 | 1.22951870 |
70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.22923128 |
71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21571272 |
72 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18777058 |
73 | ABC transporters_Homo sapiens_hsa02010 | 1.17355952 |
74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14427760 |
75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13949002 |
76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13581079 |
77 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12771213 |
78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11056487 |
79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09704402 |
80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09279941 |
81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05471668 |
82 | Influenza A_Homo sapiens_hsa05164 | 1.05145711 |
83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.03883863 |
84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02027386 |
85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01918395 |
86 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.00906476 |
87 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.00002295 |
88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99754803 |
89 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99504822 |
90 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.99199808 |
91 | Salmonella infection_Homo sapiens_hsa05132 | 0.99157404 |
92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98329683 |
93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93352496 |
94 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90925838 |
95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90357228 |
96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89942711 |
97 | Measles_Homo sapiens_hsa05162 | 0.89839034 |
98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87501064 |
99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86877796 |
100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84769464 |
101 | Lysine degradation_Homo sapiens_hsa00310 | 0.83905904 |
102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83800768 |
103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81563246 |
104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80163359 |
105 | Apoptosis_Homo sapiens_hsa04210 | 0.79778497 |
106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.79670403 |
107 | Shigellosis_Homo sapiens_hsa05131 | 0.79586280 |
108 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79370979 |
109 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75964183 |
110 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75590316 |
111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75081595 |
112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74786345 |
113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73946485 |
114 | Hepatitis B_Homo sapiens_hsa05161 | 0.72783430 |
115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70998670 |
116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68993573 |
117 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67402038 |
118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66986409 |
119 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63826960 |
120 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63578144 |
121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63485700 |
122 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.61265136 |
123 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60797441 |
124 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60361567 |
125 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59663466 |
126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59112957 |
127 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58775745 |
128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57940731 |
129 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57191816 |
130 | Endocytosis_Homo sapiens_hsa04144 | 0.54516335 |
131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49921288 |
132 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49744184 |
133 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48363512 |
134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46466526 |
135 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46291323 |
136 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45158580 |
137 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42767382 |
138 | Bladder cancer_Homo sapiens_hsa05219 | 0.41888136 |
139 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.40394467 |
140 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37023043 |
141 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36353944 |
142 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33864479 |
143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33562793 |
144 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32713534 |
145 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31327115 |
146 | Prion diseases_Homo sapiens_hsa05020 | 0.31065696 |
147 | Insulin resistance_Homo sapiens_hsa04931 | 0.28474129 |
148 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27846074 |
149 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27429082 |
150 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.26924690 |
151 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25164966 |
152 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23504843 |
153 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18704354 |
154 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18134238 |
155 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14153784 |
156 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13347762 |
157 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.02178279 |
158 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2209242 |
159 | Amoebiasis_Homo sapiens_hsa05146 | -0.2208976 |
160 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2171935 |
161 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2052115 |
162 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1957932 |
163 | Hepatitis C_Homo sapiens_hsa05160 | -0.1809585 |
164 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1789626 |
165 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1770740 |
166 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1708286 |
167 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1587654 |
168 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1488084 |
169 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1426980 |
170 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1283175 |
171 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1238754 |
172 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1219309 |
173 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1216682 |
174 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1209185 |
175 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0910017 |
176 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0851712 |
177 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0286595 |